Researchers discover class of anti-malaria antibodies

Published on January 3, 2025

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

Continue reading on website
Other news

Officials assess threat of H5N1 avian flu

January 2, 2025
Highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) remains a low risk to the general public, and public health experts in the United States believe that available treatments and vaccines, as well as those in development, are sufficient to prevent severe disease.

T cells' capability to fully prevent acute viral infections opens new avenues for vaccine development

January 10, 2025
Scientists have discovered that T cells -- white blood cells that can destroy harmful pathogens -- can completely prevent viral infection, to an extent previously thought only possible due to neutralizing antibodies. Their findings reshape our understanding of how our immune system works, paving the way for the design of more effective vaccines.